Prestige Wealth Management Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.11K | Hold |
80
| – | – | ﹤0.01% | 652 |
|
|
2025
Q1 | $3.13K | Hold |
80
| – | – | ﹤0.01% | 652 |
|
|
2024
Q4 | $2.74K | Hold |
80
| – | – | ﹤0.01% | 720 |
|
|
2024
Q3 | $3.3K | Hold |
80
| – | – | ﹤0.01% | 678 |
|
|
2024
Q2 | $3.14K | Sell |
80
-80
| -50% | -$3.14K | ﹤0.01% | 633 |
|
|
2024
Q1 | $6.92K | Hold |
160
| – | – | ﹤0.01% | 510 |
|
|
2023
Q4 | $5.99K | Hold |
160
| – | – | ﹤0.01% | 550 |
|
|
2023
Q3 | $5.86K | Hold |
160
| – | – | ﹤0.01% | 546 |
|
|
2023
Q2 | $5.76K | Hold |
160
| – | – | ﹤0.01% | 557 |
|
|
2023
Q1 | $5.75K | Hold |
160
| – | – | ﹤0.01% | 536 |
|
|
2022
Q4 | $5.68K | Hold |
160
| – | – | ﹤0.01% | 584 |
|
|
2022
Q3 | $5K | Hold |
160
| – | – | ﹤0.01% | 553 |
|
|
2022
Q2 | $9K | Hold |
160
| – | – | ﹤0.01% | 455 |
|
|
2022
Q1 | $9K | Hold |
160
| – | – | ﹤0.01% | 485 |
|
|
2021
Q4 | $9K | Hold |
160
| – | – | ﹤0.01% | 499 |
|
|
2021
Q3 | $8K | Hold |
160
| – | – | ﹤0.01% | 530 |
|
|
2021
Q2 | $8K | Hold |
160
| – | – | ﹤0.01% | 525 |
|
|
2021
Q1 | $7K | Hold |
160
| – | – | ﹤0.01% | 550 |
|
|
2020
Q4 | $7K | Sell |
160
-19
| -11% | -$831 | ﹤0.01% | 511 |
|
|
2020
Q3 | $9K | Hold |
179
| – | – | ﹤0.01% | 455 |
|
|
2020
Q2 | $9K | Sell |
179
-4
| -2% | -$201 | ﹤0.01% | 437 |
|
|
2020
Q1 | $9K | Sell |
183
-359
| -66% | -$17.7K | ﹤0.01% | 396 |
|
|
2019
Q4 | $31K | Buy |
542
+23
| +4% | +$1.32K | 0.02% | 244 |
|
|
2019
Q3 | $28K | Hold |
519
| – | – | 0.02% | 241 |
|
|
2019
Q2 | $26K | Sell |
519
-14
| -3% | -$701 | 0.02% | 241 |
|
|
2019
Q1 | $27K | Buy |
533
+70
| +15% | +$3.55K | 0.02% | 240 |
|
|
2018
Q4 | $22K | Buy |
+463
| New | +$22K | 0.02% | 287 |
|